Charming Medical Limited Class A Ordinary Shares·Healthcare
LOS ANGELES, Feb. 17, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Charming Medical Limited, (“Charming Medical” or the "Company") (NASDAQ: MCTA) investors off a class action on behalf of investors that bought securities between October 21, 2025, and November 12, 2025, inclusive (the “Class Period”). Charming Medical investors have until February 17, 2026 to file a lead plaintiff motion.
LOS ANGELES, Feb. 16, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Charming Medical Limited ("Charming " or "the Company") (NASDAQ: MCTA ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of MCTA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.
LOS ANGELES, Feb. 16, 2026 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Charming Medical Limited ("Charming" or "the Company") (NASDAQ: MCTA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between October 21, 2025, and November 12, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before February 17, 2026.
LOS ANGELES, Feb. 16, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Charming Medical Limited (“Charming” or “the Company”) (NASDAQ: MCTA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between October 21, 2025, and November 12, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before February 17, 2026.
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Charming (MCTA) To Contact Him Directly To Discuss Their Options
LOS ANGELES, Feb. 13, 2026 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Charming Medical Limited ("Charming" or "the Company") (NASDAQ: MCTA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between October 21, 2025, and November 12, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before February 17, 2026.
